Tiziana Life Sciences Ltd (TLSA)
NASDAQ: TLSA · Real-Time Price · USD
0.952
-0.018 (-1.84%)
Nov 22, 2024, 4:00 PM EST - Market closed

Tiziana Life Sciences Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Jun '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Selling, General & Admin
8.49.871.6314.1724.426.21
Upgrade
Research & Development
7.48.1112.9613.215.993.71
Upgrade
Operating Expenses
15.817.9814.5927.3730.419.92
Upgrade
Operating Income
-15.8-17.98-14.59-27.37-30.41-9.92
Upgrade
Interest Expense
-0.01-0.01-0.01-0.18-0.32-0.09
Upgrade
Interest & Investment Income
1.271.150.03-0.010
Upgrade
Other Non Operating Income (Expenses)
--0.030.89--
Upgrade
EBT Excluding Unusual Items
-14.54-16.84-14.53-26.66-30.72-10.01
Upgrade
Gain (Loss) on Sale of Investments
-2.07-0.4-0.87---
Upgrade
Gain (Loss) on Sale of Assets
----2.66-
Upgrade
Asset Writedown
-----0.28-
Upgrade
Pretax Income
-16.61-17.24-15.4-26.66-28.34-10.01
Upgrade
Income Tax Expense
-2.880.45--3.24-2.21-0.69
Upgrade
Net Income
-13.73-17.69-15.4-23.42-26.13-9.32
Upgrade
Net Income to Common
-13.73-17.69-15.4-23.42-26.13-9.32
Upgrade
Shares Outstanding (Basic)
103102102989797
Upgrade
Shares Outstanding (Diluted)
103102102989797
Upgrade
Shares Change (YoY)
-0.78%0.93%3.67%0.64%--23.71%
Upgrade
EPS (Basic)
-0.13-0.17-0.15-0.24-0.27-0.10
Upgrade
EPS (Diluted)
-0.13-0.17-0.15-0.24-0.27-0.10
Upgrade
Free Cash Flow
-3.92-15.7-19.62-21.78-11.34-6.8
Upgrade
Free Cash Flow Per Share
-0.04-0.15-0.19-0.22-0.12-0.07
Upgrade
EBITDA
-15.79-17.98-14.59-27.37-30.41-9.92
Upgrade
D&A For EBITDA
0.010.0100.010.010.01
Upgrade
EBIT
-15.8-17.98-14.59-27.37-30.41-9.92
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.